chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 8-12 hours of receiving vaccine: 1) Developed fever of 101.5 which lasted for at least 16 hours.  Temperature reduced to 99.5 by taking 200 mg Advil or 325 mg Tylenol at 5 hour intervals.  Temperature returned to 98.6 approximately 24 hours after onset, 36 hours after vaccination. 2) Severe body aches, particularly hips, lower back, chest.  Alleviated by Advil/Tylenol.  Symptoms lessened approximately 24 hours after onset, 36 hours after vaccination, but still required 200mg Advil 42 hours after vaccination to alleviate. 3) Scalp and skin ached.  Felt like I had been swatted all over my body with a tennis racquet. 4) Very bad headache.  Any head movement (turning over in bed) increased head ache.
Patient did not show for 2nd dose appointment scheduled for 5/15/21.  Clinic staff contacted caregiver who notified that patient had expired 10 days after her first dose of Moderna.
Pt was given incorrect formulation of the Moderna vaccine.  Pt. received Moderna 6m-5y (Blue cap) vaccine but should have received Moderna 12+ (Red cap) vaccine.
This spontaneous report as received from a Registered Nurse refers to a unspecified number of patients of unknown gender and unknown age. It was reported that on an unknown date, the unspecified number of patients received unspecified doses of GARDASIL, (dose number, lot/batch number, expiration date, route of administration not reported) that were improperly stored from 20-MAR-2014 to 07-MAY-2014. Nurse stated that vaccines were exposed to 10.5C for 56.05 hours cumulatively through 07-MAY-2014. It was reported that also M-M-R II, PNEUMOVAX, ROTATEQ and PEDVAX were improperly stored (event captured in MARRS# 1405USA012894, 1406USA000956, 1406USA000957 and 1406USA000958 respectively). No adverse effects were reported. This is one of several reports from the same reporter. Follow-up information has been received from the Registered Nurse. It was reported that the nurse was inquiring about temperature excursions that occurred from October 2013 to March 2014. The nurse also stated they were replacing the refrigerator, freezer, and the data logger and were sending the old data logger for calibration to the health department. All telephone attempts to obtain follow up information have been unsuccessful. Follow up information has been received from Registered Nurse on 27-JUN-2014. The nurse stated that three doses of GARDASIL (Lot#J003727, expiration date 7-NOV-2015, dose not reported) that were improperly stored from 28-AUG-2013 to June 2014 were administered to unspecified patients (unknown age and gender) on an unknown dates (2 doses were exposed for 269 hours to highest temperature of 9C and one dose for 271 hours to 10C). Additional information is not expected.
I became sluggish at first, then just wanted to sleep, woke up and all my muscles in my body seemed to be on fire.  Pain was quite intense.  I would say on scale of 1-10 a 10.   Felt like a very bad case of my Crohns coming on.  I took Tylenol for pain relief every 4-6 hours.  From Friday evening through Saturday March the 6th I had no appetite did not have strength to hardly leave the bed.  I had some stomach cramping and diarrhea on morning of March 6th.  I slept and off for close to 38 hours.  I could not make a fist with my left hand at all and had very little strength in my right side.  I ran a slight fever of 99.My head was splitting.  My husband had the vaccine on March 2nd and he had only slight discomfort and weakness for about 16 hours.  Said he felt like he had a hangover.  I was expecting some type of reaction but decided Saturday evening if I got any worse I would go to urgent care.  I slept about 5 solid hours on March 6/7 and awoke Sunday morning feeling somewhat better.  Pain was at about a 5.   Today March 8, 2021 I am feeling better, just weak, still no appetite, headache has eased and I can grip both left and right hand now.  I am better today than yesterday.  I will continue to monitor myself.   With my history of Crohn's I am very aware of body and how it reacts.   My normal is not everyone's normal, but want to make you aware of how miserable I was.  I am thankful I received and pray that his helps me to not get Covid.   If you have further questions, please do not hesitate to contact me.
pt recvd vax & was screaming over 3 hrs; tx w/ apap every 4 hrs; tx changed to advil;
I had an itch that comes and go, it would swell and then go away. It would happen all over my body. I thought it was allergies, then I went back to the pharmacy and was told to take Allegra. I continued to have the itch and scheduled an appointment with an Allergist. The Allergist stated it was a reaction to the vaccine.
Joint pain in shoulders, elbows, hands, knees, ankles, feet and toes. Malaise, nausea, chills, headaches, and fatigue.
Pt had AVA and Influenza shot on 4/14/09 and SPV 4/16/09.  She returned to the Imm Clinic on 4/23/09 for evaluation of SPV (major take); pt requested a pg test which was positive (LMP 3/16/09).  Pt indicated that she was not pg on the SPV questionnaire.  Symptoms:  Amenorrhea.
fever 101; intense body aches all over; chills; nasty headache; extreme fatigue; really miserable; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache) and FATIGUE (extreme fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache), FATIGUE (extreme fatigue) and FEELING ABNORMAL (really miserable). At the time of the report, PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache), FATIGUE (extreme fatigue) and FEELING ABNORMAL (really miserable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Aleve (Naproxen).
DOSE 4 (BOOSTER); DOSE 4 (BOOSTER); sore arm-no big deal; violent chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID:. The reporter is the patient.  An 81-year-old female patient received bnt162b2 (COMIRNATY), as dose 4 (booster), single (Batch/Lot number: unknown) intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization, reaction(s): "violent chills", "sore arm-no big deal"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 Immunization, reaction(s): "violent chills", "sore arm-no big deal"; Bnt162b2 (DOSE 3, SINGLE), for COVID-19 Immunization, reaction(s): "violent chills", "sore arm-no big deal". The following information was reported: OFF LABEL USE (non-serious), IMMUNISATION (non-serious), outcome "unknown" and all described as "DOSE 4 (BOOSTER)"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "sore arm-no big deal"; CHILLS (non-serious), outcome "unknown", described as "violent chills".  Additional information: With the previous Pfizer Covid vaccinations, she felt all of them go into her arm muscle. Patient reported that she felt it go into her muscle and she got a bit of a sore arm-no big deal. Then about twelve hours later on the money every time, she has gotten violent chills that last about another 12 hours or so.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300322049 Same reporter, Patient / Different AE, Vaccine Dose;US-PFIZER INC-202300322023 Same reporter, Patient / Different AE, Vaccine Dose;US-PFIZER INC-202300322046 Same reporter, Patient / Different AE, Vaccine Dose;
This spontaneous report was received from a medical assistant regarding 8 patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored ROTATEQ. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a consumer who saw via video clip online last month concerning a male "little kid" who was vaccinated with MMR II.  Subsequently the patient could not speak and was frustrated.  The parents of the patient stated that their child was vaccinated with MMR II and then developed autism.  The patient had sought unspecified medical attention.  The patient's can not speak persisted.  The patient's autism and aphasia persisted.  Attempts are being made to verify the existence of an identifiable patient.  Upon internal review aphasia and autism were considered to be other important medical events.  No further information is available.
I had a proper menstrual cycle for the first time in 8 years, including  bleeding, cramping, bloating, and increased appetite. My birth control allows for continuous use so that I do not have bleeding or any other symptoms, and have not had a period since 2013. If I followed my typical menstrual cycle, it would have happened 2 weeks after this adverse reaction occurred. I have experiences heavy bleeding, painful cramps, and bloating for 4 days now.
Vertigo; Nystagmus; He could not get up; Dizziness; He felt like he was going to pass out and almost did pass out at one point; Nausea; Vomiting; This spontaneous case was received on 24-Dec-2020 from physician via The Agency (reference number: SEQW20-05936) and concerned a 64-year-old male patient.  The patient's medical history and concomitant medications were not reported.  On 28-Oct-2020, the patient was vaccinated with Flucelvax Quadrivalent vaccine (influenza vaccine, subunit influenza virus vaccine polyvalent; dose, route of administration and anatomical location: not reported) for protection against seasonal influenza. The batch number reported was 276541, expiration date: 16-Jun-2021.  On the same day, 10 hours after receiving Flucelvax Quadrivalent, the patient experienced extreme dizziness and vertigo, he stated that that it was real vertigo and severe, with the sensation that the room was spinning. The patient reported that, during this episode, he felt like he was going to pass out and almost did pass out at one point. During this time, he could not get up and was experiencing nystagmus. The patient was experiencing nausea and vomiting during this time. The patient stated that all of these adverse effects lasted about three hours.  On the same day, the patient recovered from all events.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company Comment: A 55-year-old female patient developed vertigo, nystagmus, dysstasia, dizziness, presyncope, presyncope, nausea and vomiting on the same day after vaccination with the suspect product, Flucelvax Quadrivalent. Information regarding the underlying medical history, related diagnostic findings and concomitant medications have not been provided. Based on plausible time relationship, causality cannot be totally excluded and is assessed as possibly related.; Sender's Comments: A 55-year-old female patient developed vertigo, nystagmus, dysstasia, dizziness, presyncope, presyncope, nausea and vomiting on the same day after vaccination with the suspect product, Flucelvax Quadrivalent. Information regarding the underlying medical history, related diagnostic findings and concomitant medications have not been provided. Based on plausible time relationship, causality cannot be totally excluded and is assessed as possibly related.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included polyhydroaminos.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 05-Jul-2021. On 01-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 01-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: pregnancy Form
Within 24 hours red, swollen, tender, hot to the touch, headaches, lethargy,
Equipment malfunction. When I pressed on the plunger, the vaccine,(liquid) leaked down his arm. Very little to no vaccine was administered.   I prepared and administered a second vaccine with no issues.
This spontaneous report was received from a physician via company representative and refers to a female patient of unknown age. No pertinent medical history or concurrent conditions were reported, the patient was not reported to be pregnant. On 11-JUN-2015, the patient was vaccinated with her first dose of GARDASIL 0.5 ml through an unspecified route. No concomitant medications were reported. The reporter confirmed that patient received GARDASIL and not GARDASIL 9. On 11-JUN-2015, after receiving the first dose of vaccine, the patient felt woozy and experienced vomiting before leaving the office. The patient sought medical attention with her doctor but did not receive treatment for the events. The outcome of the events wooziness and vomiting was unknown. The reporter did not assess the causality of the events with GARDASIL. Additional information has been requested.
Reprot 20010086071 described whole body rash in a 30 year old female who received hep B vaccine (brand unknown) for prophylaxis of hep B. The vaccinee denied allergies, medical history and concomitant medications. On 01/16/2001, the vaccinee received her first dose of hep B vaccine. Twelve to twenty-four hours post vaccination, she experienced a whole body rash. The vaccinee self-treated and was not give the second hep B vaccine dose. As of 04/03/2001, the outcome of the event is resolved.
This case involves a female patient who experienced flu (influenza) after receiving INFLUENZA VACCINE.   It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "The only one who ever got the flu shot was my mother and she was the only one to get severely sick with the flu. My son did it one time and he got very sick. Nope I will rely on my immune system."  There were no lab data/results available.  It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information on the batch number for this case.
After receiving the vaccine I have experienced chronic pain, fatigue, shortness of breath, tingling in my fingers and toes, and generally feeling ?off?.
Pt. arm below the injection site became red, swollen and itchy.  This was not at the injection site and traveled to the sides of arm and down toward elbow.  The next day he had pain in his arm pit.  Pediatrician says it was a localized reaction.  Next day 11/18/2011 he still had pain in arm pit and additional pain in leg and eye.  All on same side of injection site.
Patients wife stated he took a nap after the flu shot and woke up with really red blood shot eyes. Also complaints of body aches and chills. Was taking a cold shower. Has lasted for a couple hours now. Patient is diabetic and has a sensor he wears on the opposite arm. Complained of arm soreness also. wife was most concerned about the blood shot eyes.
1st dose on February 10, 2022 and 2nd dose on February 24, 2022; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too short in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 24th February 2022, the patient received the 2nd dose of Shingrix. On 24th February 2022, unknown after receiving Shingrix and an unknown time after receiving SHINGRIX, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The reporter was the patient's wife. The patient received 2nd dose of Shingrix in left arm. The patient received 2nd dose of Shingrix, earlier than the recommended schedule, which led to shortening of vaccination schedule. This adverse event was reported due to the incorrect vaccination schedule that was applied. The reporter did not have further information regarding the 2nd dose of Shingrix. The call center representative spoke per PI, offered PI, gave Medical Advice Disclaimer and referred to healthcare professional.   Offered phone number to MI for healthcare professional to call on patient's behalf.  The reporter did not consent to follow-up.
drooping right eye lid and right side of mouth .  Diagnosised as Bell's Palsy.  Had the same reaction after 2nd dose
exacerbated her PHN /taking herpes medication to help with the PHN pain; Pain; exacerbated her PHN; This case was reported by a consumer via call center representative and described the occurrence of post herpetic neuralgia in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included post herpetic neuralgia and shingles. Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced post herpetic neuralgia, pain and condition aggravated. On an unknown date, the outcome of the post herpetic neuralgia, pain and condition aggravated were not recovered/not resolved.   The reporter considered the post herpetic neuralgia, pain and condition aggravated to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient for herself. The age at vaccination was not reported. The patient received 2 doses of Shingrix 19 months ago and post herpetic neuralgia was flare-up lasted for the past 19 months since the patient got her last dose of Shingrix. The patient believed that the Shingrix vaccine may had exacerbated her post herpetic neuralgia symptoms and made her post herpetic neuralgia last longer. The patient also mentioned that taking herpes medication from a friend to be seen if it would be help with the post herpetic neuralgia pain. Referred her to health care professional. MI phone number was provided. The reporter consented to follow-up.
Information has been received from a consumer reporting that her daughter, who was vaccinated with GARDASIL (lot #, route and dose not reported) "few years ago", had experienced hair loss. No further information is available.
had dizziness and fatigue shortly after first vaccine, extreme sinus drainage started a couple days later, had 4 migraines in 2 weeks after vaccine, had stomach ache/nausea that started within a couple weeks after. saw pcp 3 times 1/11/21 through 1/21/21. dizziness lasted about 3 weeks. treated it with motion sickness medication (OTC). treated sinus drainage with neti pot, OTC allergy medicine, and Flonase spray. treated migraines with naratriptan and zofran and aleve. after second vaccine on 1/27/21, had dysphasia. saw PCP for this on 4/9/21, 5/4/21, and had endoscopy on 6/25/21-results showed narrowing of and inflammation of esophogus.  have also had increased frequency of migraines since COVID vaccines. Have had 20 already in 2021, while only had 18 total in 2020.
A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 11 month old male vaccinee was inadvertently administered Fluvirin IM on 12Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200805, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Patient experience adverse reaction after first dose on new SHINGRIX vaccine. Patient developed body aches, fever ranging from 99 to 100.3, and chest discomfort. Patient was having sharp pains in stomach and a bright red rash (rash eventually turned pink and became itchy). Patient took TYLENOL for a few days post shot and was instructed to see MD/ER is symptoms worsened. Patient came in to pharmacy today 3-11-19 and was feeling better but still not 100%. Patient still had some topical symptoms but other symptoms had improved (suggested some BENADRYL to help with itching as well). Patient is not likely to get second dose.
2 "spots" started on face, progressed to cover entire boy; low grade fever maybe 101-102 which lasted 4 days prior to eruption of rash;loss of appetite; sleeping changes; irritable, fussy;